Results 11 to 20 of about 36,741 (290)
Post-Transplant Diabetes: Prevalence, Risk, and Management Challenges
Dubai Diabetes and Endocrinology Journal, 2022 The prevalence of diabetes and diabetic nephropathy is increasing, especially in middle eastern countries. Many patients reach end-stage renal disease and either start dialysis or consider preemptive transplantation.
Alaaeldin M.K. Bashier +5 more
doaj +1 more source
Journal of Pharmaceutical Health Care and Sciences, 2020 Background Patients with diabetes are at higher risk of developing polypharmacy because of the high frequency of comorbidities. There have been several reports on the hypoglycemic risk of the combination of hypoglycemic agents and other medications. This
Tomoyuki Saito +3 more
doaj +1 more source
Oman Medical Journal, 2022 Sodium-glucose cotransporter type 2 inhibitors (SGLT2i) are oral hypoglycemic agents that have insulin-independent glucose-lowering effects mediated by increasing the renal excretion of glucose by inhibiting the SGLT2-mediated renal glucose reabsorption.
Raya Almazrouei +5 more
doaj +1 more source
The Study of Hypoglycemic Activity of 7-Terpenylcoumarins
Molecules, 2022 Natural and synthetic coumarins are often considered privileged scaffolds for obtaining pharmacological agents with hypoglycemic activity. Chemical modification of coumarins often leads to antidiabetic agents with greater efficacy.
Sergey Kuranov +10 more
doaj +1 more source
EFFECT OF CHLOROQUINE ON BLOOD GLUCOSE LEVELS IN PATIENTS WITH NON INSULIN DEPENDENT DIABETES MELLITUS [PDF]
Acta Medica Iranica, 1998 77irty six patients with non insulin dependent diabetes mellitus, whose blood sugar was not controlled with maximal doses of oral hypoglycemic agents and did not accept insulin treatment, were selected for this study.
H. Mostafavi
doaj +1 more source
Treatment patterns in type 2 diabetes mellitus: A cross-sectional study
Indian Journal of Health Sciences and Biomedical Research KLEU, 2017 Introduction: Diabetes is one of the most common noncommunicable diseases in the world. There is an epidemic of diabetes in developing and nondeveloping countries.
Dhongadi Prashant, Sanjay Kambar
doaj +1 more source
Hypoglycemic agents and prognostic outcomes of chronic kidney disease patients with type 2 diabetes [PDF]
Journal of Nephropathology, 2023 Introduction: Chronic kidney disease (CKD) poses a financial burden on most patients from low/ middle income countries. Glycaemic control with affordable hypoglycemic agents may influence on the prognosis of diabetic nephropathy.
Kyaw Kyaw Hoe +2 more
doaj +1 more source
Dipeptidyl Peptidase-4 Inhibitors and Diabetic Kidney Disease: A Narrative Review
Kidney Medicine, 2021 Diabetic kidney disease is one of the most frequent complications in patients with diabetes mellitus and affects morbidity and mortality. The recent therapies include oral hypoglycemic drugs that, in addition to optimizing glycemic control and reducing ...
Rodrigo Daza-Arnedo +10 more
doaj +1 more source
Sulfonylurea and neuroprotection: The bright side of the moon
Journal of Advanced Pharmaceutical Technology & Research, 2018 Sulfonylurea (SUR) agents are the second and most used oral hypoglycemic drugs after metformin and they still as an imperative tool for most favorable of glucose control.
Nawar R Hussien +4 more
doaj +1 more source
Insulin and Oral Hypoglycemic Drug Overdose in Post-Mortem Investigations: A Literature Review
Biomedicines, 2022 Background and Objectives: Insulin and oral hypoglycemic agents are drugs widely used in the world population due to their therapeutic effects on diabetes mellitus. Despite these benefits, they can also cause accidental or voluntary drug overdose.
Alice Chiara Manetti +6 more
doaj +1 more source